These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 30927190)

  • 1. Prevention of complications from use of conventional immunosuppressants: a critical review.
    Ponticelli C; Glassock RJ
    J Nephrol; 2019 Dec; 32(6):851-870. PubMed ID: 30927190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs.
    Parlakpinar H; Gunata M
    Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):651-665. PubMed ID: 34415233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppressive treatment].
    Niaudet P
    Nephrol Ther; 2011 Dec; 7(7):592-8. PubMed ID: 22118788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin inhibitors in renal transplantation: what is the best option?
    Tanabe K
    Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin inhibitors in pediatric renal transplant recipients.
    Filler G
    Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid- and calcineurin inhibitor free immunosuppression in kidney transplantation: state of the art and future developments.
    Giessing M; Fuller TF; Tuellmann M; Slowinski T; Budde K; Liefeldt L
    World J Urol; 2007 Jun; 25(3):325-32. PubMed ID: 17333201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression and Heart Transplantation.
    Sutaria N; Sylvia L; DeNofrio D
    Handb Exp Pharmacol; 2022; 272():117-137. PubMed ID: 34671867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current trends in immunosuppressive therapies for renal transplant recipients.
    Lee RA; Gabardi S
    Am J Health Syst Pharm; 2012 Nov; 69(22):1961-75. PubMed ID: 23135563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research database.
    Tsai SF; Cheng CY; Shu KH; Wu MJ
    Transplant Proc; 2012 Jan; 44(1):190-2. PubMed ID: 22310612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.
    Bakr MA; Gheith OA; Ismael AM; Baz ME; Shehab El-Dein AB; Ghoneim MA
    Exp Clin Transplant; 2008 Mar; 6(1):48-53. PubMed ID: 18405245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced exposure to calcineurin inhibitors in renal transplantation.
    Ekberg H; Tedesco-Silva H; Demirbas A; Vítko S; Nashan B; Gürkan A; Margreiter R; Hugo C; Grinyó JM; Frei U; Vanrenterghem Y; Daloze P; Halloran PF;
    N Engl J Med; 2007 Dec; 357(25):2562-75. PubMed ID: 18094377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Status Regarding Immunosuppressive Treatment in Patients after Renal Transplantation.
    Szumilas K; Wilk A; Wiśniewski P; Gimpel A; Dziedziejko V; Kipp M; Pawlik A
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation.
    Wong TC; Lo CM; Fung JY
    Expert Opin Emerg Drugs; 2017 Jun; 22(2):123-136. PubMed ID: 28503959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated.
    Chang GJ; Mahanty HD; Quan D; Freise CE; Ascher NL; Roberts JP; Stock PG; Hirose R
    Liver Transpl; 2000 Nov; 6(6):734-40. PubMed ID: 11084060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Present and future of immunosuppressive therapy in kidney transplantation.
    Ponticelli C
    Transplant Proc; 2011; 43(6):2439-40. PubMed ID: 21839286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modern immunosuppression following renal transplantation. Standard or tailor made?].
    Budde K; Giessing M; Liefeldt L; Neumayer HH; Glander P
    Urologe A; 2006 Jan; 45(1):9-17. PubMed ID: 16328215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunosuppressive drugs and renal transplantation].
    Stallone G; Infante B; Gesualdo L
    G Ital Nefrol; 2005; 22 Suppl 33():S76-9. PubMed ID: 16419011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.